The recurring motif of Biosafety Level 4 (BSL-4) laboratories highlights a central tension in efforts to defend against biological threats: facilities designed to study and contain dangerous pathogens can themselves introduce risks of accidental release and misuse. These maximum-containment facilities are designed to house the world’s most dangerous pathogens. The narrative presents the Russian Vector Institute as the site where the scenario’s outbreak begins and the American USAMRIID as the facility tasked with analyzing the pathogen. Their different roles illustrate how high-containment laboratories can be associated with both biological risk and biological defense. Jacobsen also shows how the post-9/11 proliferation of these labs expanded the number of facilities conducting research on dangerous pathogens while raising concerns about oversight. A 2007 congressional audit found that during this expansion, “No single federal agency has the mission to track and determine the risk associated with the expansion of BSL-3 and BSL-4 labs” (34), highlighting the lack of centralized oversight as the number of high-containment laboratories increased.

The BSL-4 laboratory motif supports the theme of The Weaponization of Scientific Progress by illustrating the uncertain boundary between research intended for biological defense and research that can create new biological risks. Despite their advanced containment systems, these facilities cannot eliminate the risks associated with accidents or the deliberate misuse of the pathogens and technologies they contain. The explosion at Vector that initiates the scenario gives this danger concrete form: a facility intended to contain dangerous pathogens becomes the site from which the biological crisis begins. Later, USAMRIID’s role in analyzing the pathogen presents the other side of the motif, as high-containment research becomes essential to understanding the same threat. Through these contrasting functions, BSL-4 laboratories embody the dual-use problem at the center of Jacobsen’s treatment of modern biological research: scientific capabilities developed for protection can also create dangers of their own.

Los Angeles’s Skid Row is a powerful symbol of a critical gap in the nation’s public health infrastructure, particularly the exclusion of vulnerable populations from disease surveillance. The scenario makes Skid Row one of the earliest major outbreak sites, a fifty-square-block area where thousands of unhoused individuals remain largely outside the purview of formal disease-surveillance systems. Its role in the outbreak illustrates how gaps in surveillance among marginalized populations can weaken the wider public health response. The narrative emphasizes this vulnerability by noting that the CDC’s multibillion-dollar BioSense surveillance program, intended as a “national radar” for outbreaks, does not include data from homeless shelters or clinics. As infectious disease expert Dr. Michael V. Callahan describes these densely concentrated vulnerable populations, they “[present] an accident waiting to happen” (109), while their exclusion from BioSense creates a critical blind spot that allows the plague to spread before the outbreak is recognized.

The initial LAPD response, which misidentifies the plague outbreak as a mass fentanyl overdose, further highlights the consequences of this blind spot. Because mass fentanyl overdoses have become commonplace in homeless encampments, officials initially interpret the emerging outbreak within the context of an existing public health crisis. Skid Row therefore becomes a symbol of the consequences of leaving vulnerable populations outside systems designed to detect emerging disease. The subsequent spread of the plague from this early outbreak site into the wider population demonstrates that gaps in disease surveillance can have consequences extending beyond the populations initially affected. In this way, Skid Row supports the theme of The Fragility of Modern Infrastructure by exposing a significant weakness within an otherwise sophisticated national disease-surveillance system.